Marc Buyse is founder and board member of IDDI and associate professor of biostatistics at the Universiteit Hasselt. He holds degrees in engineering and statistics from Brussels University (ULB), management from the Cranfield School of Management (Cranfield, U.K.), and a doctorate in biostatistics from Harvard University (Boston, MA). He was the recipient of several research fellowships in Belgium, the U.S., and Japan. He was president of the International Society for Clinical Biostatistics, president of the Quetelet Society, and fellow of the Society for Clinical Trials. He worked at the EORTC (European Organization for Research and Treatment of Cancer) in Brussels and at the Dana Farber Cancer Institute in Boston prior to founding IDDI in 1991. He has published extensively in the fields of clinical trial methodology, meta-analysis, statistical detection of fraud, validation of biomarkers and surrogate endpoints, and drug development in oncology and ophthalmology.

Back to Team